New Journey Health Technology Group Co., Ltd.Class A

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A carries a market capitalization of 5.97B, placing it among publicly traded companies globally. Its enterprise value stands at 7.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

New Journey Health Technology Group Co., Ltd.Class A's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A has 3.45B shares outstanding.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A trades at a trailing price-to-earnings ratio of 190.64. The price-to-sales ratio is 2.03, and the price-to-book ratio stands at 3.02.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A trades at an EV/EBITDA multiple of 78.92 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.61 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 78.92 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 7.50B versus a market cap of 5.97B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A maintains a current ratio of 0.55, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 90.20, indicating elevated leverage, while an interest coverage ratio of 0.79 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A posted a return on equity (ROE) of 1.53, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.26 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.46, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.09, useful for judging operating efficiency across full business cycles. The company generates approximately 314,990.73 in revenue per employee across its workforce of 9,108.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A recorded 48.96M in income tax expense. That works out to an effective tax rate of 52.90, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 92.56M, leaving 30.54M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, New Journey Health Technology Group Co., Ltd.Class A's stock has declined approximately 19.41% over the past 52 weeks. The 50-day moving average sits at 2.15, while the 200-day moving average is 2.22.

Over the twelve months ended June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A generated 2.87B in revenue and converted that into 30.54M in net income, yielding earnings per share of 0.01. EBITDA reached 95.03M, while operating income came in at 286.17M.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A holds 368.32M in cash and equivalents against 1.84B in total debt, resulting in a net debt position of 931.52M. Total book value stands at 1.98B, with working capital of -1.58B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of 9.97 and net profit margin of 1.06 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A paid dividends of 0.02 per share. The dividend payout ratio of 181.69 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

New Journey Health Technology Group Co., Ltd.Class A's most recent stock split took place on October 28, 2015 with a 2:5 split ratio.

As of June 30, 2026, New Journey Health Technology Group Co., Ltd.Class A has an Altman Z-Score of 0.35, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.